Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)
Clinical trial NCT05878184 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05878184
- Sponsor
- Sana Biotechnology
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-02
- Primary completion
- 2025-11-04
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.